Novo Integrated Sciences Inc (NVOS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 08/31
| 02-2022 | 11-2021 | 08-2021 | 05-2021 | 02-2021 | |
| Sales | 2,869 | 3,162 | 2,693 | 2,381 | 2,076 |
| Cost of Goods | 1,653 | 1,896 | 1,713 | 1,101 | 1,324 |
| Gross Profit | 1,216 | 1,267 | 980 | 1,281 | 751 |
| Operating Expenses | 3,990 | 3,526 | 3,581 | 1,783 | 2,402 |
| Operating Income | -2,121 | -1,364 | -1,888 | -402 | -1,326 |
| Interest Expense | 1,226 | 69 | 96 | 22 | 23 |
| Other Income | -1,521 | -384 | 42 | 8 | 8 |
| Pre-tax Income | -4,868 | -1,816 | -1,942 | -415 | -1,341 |
| Net Income Continuous | -4,868 | -1,816 | -1,942 | -415 | -1,341 |
| Minority Interests | -63 | -10 | -2 | -4 | -1 |
| Net Income | $-4,805 | $-1,807 | $-1,940 | $-411 | $-1,340 |
| EPS Basic Total Ops | -1.70 | -0.70 | -0.70 | -0.20 | -0.60 |
| EPS Basic Continuous Ops | -1.69 | -0.67 | -0.75 | -0.16 | -0.56 |
| EPS Diluted Total Ops | -1.70 | -0.70 | -0.70 | -0.20 | -0.60 |
| EPS Diluted Continuous Ops | -1.69 | -0.67 | -0.75 | -0.16 | -0.56 |
| EBITDA(a) | $116 | $-612 | $-1,283 | $-21 | $-946 |